This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: This research was motivated by the widespread use of oral antivirals during the Covid-19 pandemic and the remaining uncertainty regarding their effects on viral kinetics, which have rarely been studied in real-world population cohorts of this size. METHODS: We analysed 291,340 SARS-CoV-2 cycle threshold (CT) values from 113,399 non-hospitalized adult patients in Vienna (01/2022-05/2023), including 30,451 from 12,166 nirmatrelvir-ritonavir recipients, 27,959 from 10,752 molnupiravir recipients, and 232,930 from 90,481 untreated controls. RESULTS: Both antivirals initially caused a rapid increase in mean CT values. After completion of the 5-day treatment course, CT values declined in both antiviral groups, which was not observed in untreated individuals. CONCLUSIONS: These findings provide population-level evidence on post-treatment viral kinetics of oral antivirals during the Omicron wave.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Prager et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: